BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29880091)

  • 1. New Models of Care: How Pharmacists Can Provide Better Care at Lower Costs.
    Smith M; Wick JY
    Consult Pharm; 2018 Jun; 33(6):294-304. PubMed ID: 29880091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Economic Benefits of Pharmacist Involvement in a Community Hospital-Affiliated Patient-Centered Medical Home.
    Tate ML; Hopper S; Bergeron SP
    J Manag Care Spec Pharm; 2018 Feb; 24(2):160-164. PubMed ID: 29384022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacy performance while providing continuous medication monitoring.
    Doucette WR; McDonough RP; Herald F; Goedken A; Funk J; Deninger MJ
    J Am Pharm Assoc (2003); 2017; 57(6):692-697. PubMed ID: 28844583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing the Role of Community Pharmacists in Managing the Health of Populations: Barriers, Facilitators, and Policy Recommendations.
    Newman TV; Hernandez I; Keyser D; San-Juan-Rodriguez A; Swart ECS; Shrank WH; Parekh N
    J Manag Care Spec Pharm; 2019 Sep; 25(9):995-1000. PubMed ID: 31456493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for community-based medication management services in value-based health plans.
    Smith MA; Spiggle S; McConnell B
    Res Social Adm Pharm; 2017; 13(1):48-62. PubMed ID: 26904962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing pathways for access to pharmacist-provided patient care.
    Schommer JC; Doucette WR; Planas LG
    J Am Pharm Assoc (2003); 2015; 55(6):664-668. PubMed ID: 26547600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two Medication Therapy Management Practice Models on Return on Investment.
    Gazda NP; Berenbrok LA; Ferreri SP
    J Pharm Pract; 2017 Jun; 30(3):282-285. PubMed ID: 26888260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are community-based pharmacists underused in the care of persons living with HIV? A need for structural and policy changes.
    Kibicho J; Pinkerton SD; Owczarzak J; Mkandawire-Valhmu L; Kako PM
    J Am Pharm Assoc (2003); 2015; 55(1):19-30. PubMed ID: 25575148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The paradox of pharmacy: A profession's house divided.
    Brown D
    J Am Pharm Assoc (2003); 2012; 52(6):e139-43. PubMed ID: 23143300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forging a novel provider and payer partnership in Wisconsin to compensate pharmacists for quality-driven pharmacy and medication therapy management services.
    Trapskin K; Johnson C; Cory P; Sorum S; Decker C
    J Am Pharm Assoc (2003); 2009; 49(5):642-51. PubMed ID: 19748873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacists' performance of clinical interventions during adherence support medication reviews.
    Hatah E; Tordoff J; Duffull SB; Braund R
    Res Social Adm Pharm; 2014; 10(1):185-94. PubMed ID: 23688540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving care transitions: current practice and future opportunities for pharmacists.
    ; Hume AL; Kirwin J; Bieber HL; Couchenour RL; Hall DL; Kennedy AK; LaPointe NM; Burkhardt CD; Schilli K; Seaton T; Trujillo J; Wiggins B
    Pharmacotherapy; 2012 Nov; 32(11):e326-37. PubMed ID: 23108810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Process indicators of quality clinical pharmacy services during transitions of care.
    ; Kirwin J; Canales AE; Bentley ML; Bungay K; Chan T; Dobson E; Holder RM; Johnson D; Lilliston A; Mohammad RA; Spinler SA
    Pharmacotherapy; 2012 Nov; 32(11):e338-47. PubMed ID: 23108762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyzing the costs to deliver medication therapy management services.
    Rupp MT
    J Am Pharm Assoc (2003); 2011; 51(3):e19-26; quiz e27. PubMed ID: 21555277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective financial analysis of medication therapy management services from the pharmacy's perspective.
    McDonough RP; Harthan AA; McLeese KE; Doucette WR
    J Am Pharm Assoc (2003); 2010; 50(1):62-6. PubMed ID: 20097640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Getting Paid for Clinical Services.
    Martin CM
    Consult Pharm; 2018 May; 33(5):240-246. PubMed ID: 29789045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key Value Considerations for Consultant Pharmacists.
    Meyer L; Perry RG; Rhodus SM; Stearns W
    Consult Pharm; 2016 Jul; 31(7):365-74. PubMed ID: 27412312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication reviews in primary care in Sweden: importance of clinical pharmacists' recommendations on drug-related problems.
    Modig S; Holmdahl L; Bondesson Å
    Int J Clin Pharm; 2016 Feb; 38(1):41-5. PubMed ID: 26582483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentially preventable medication-related hospitalizations: A clinical pharmacist approach to assessment, categorization, and quality improvement.
    Pellegrin KL; Lee E; Uyeno R; Ayson C; Goo R
    J Am Pharm Assoc (2003); 2017; 57(6):711-716. PubMed ID: 28823545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Provision of Clinical Preventive Services by Community Pharmacists.
    Kelling SE; Rondon-Begazo A; DiPietro Mager NA; Murphy BL; Bright DR
    Prev Chronic Dis; 2016 Oct; 13():E149. PubMed ID: 27788064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.